Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

May 17, 2019

Thermo Fisher Scientific to acquire manufacturing site in Cork, Ireland, from GSK

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline plc (NYSE: GSK) for approximately €90 million in cash.

Thermo Fisher Scientific to acquire manufacturing site in Cork, Ireland, from GSK